Form 4 · Filed Jun 25, 2026, 08:06 PM UTC
GALT/GALECTIN THERAPEUTICS INC
Jamil Khurram — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | M | other | 7,557 | $1 | $9,295 | 7,557 |
| Jun 23, 2026 | S | sell | 7,557 | $3 | $23,729 | 0 |
| Jun 23, 2026 | M | other | 7,557 | — | — | 32,500 |
Source: SEC EDGAR raw filing ↗ · Accession 0001133416-26-000057